This experiment mainly optimizes Agaricus Blazei Polipeptide (ABP) extraction technology and evaluates the protection effect on aging mice. In this study, a new single component, M 3 KD, isolated and purified from Agaricus Blazei. The aging mouse model was established using D-galactose. After the ABP administration, the contents of total antioxidant capacity (T-AOC), malondialdehyde (MDA), catalase (cat), and reactive oxygen species changed significantly. Through immunofluorescence staining, observed that ABP can reduce brain tissue changes. The expression of the generation of genes was analyzed by RNA-SEQ.
A total of 295 genes expressed differently filtered in the ABP Gen Group.rt-QPCR verify the important gene and show that the level of MRNA HSPH1, Trim32, HNRNPA1, and Grik5 expression increased significantly, and people from APOE, ATP1A3, STXBP1, and MAPK8IP1 decreased significantly. West Blotting shows that the level of expression of KAPE1 and P53 protein is significantly lower, while the level of protein expression of NRF2, HO-1, HSPH1, and TRIM32 is significantly higher in the ABP group.
ABP plays an anti-aging role in a rat aging model. Specific work mechanisms may be related to the expression regulations of the KAPE1 / NRF2 / P53 signaling path and related factors. Practical application: This research can contribute to the development of ABP as functional food or food supplements for anti-aging in the future.
Carboxyl-terminal polypeptide fragment from MUC16 Combing Stathmin1 promotes migration and bile cancer cell invasion
CA-125, encoded by Gen MUC16, is responsible for various types of tumor metastasis. However, related mechanisms are still unclear. We have set new ways to reveal gallbladder cancer metastasis related to the serum level CA-125 through C-terminal polypeptides from Gen16 production. MUC16 C-terminal polypeptides significantly promote bile cancer cell migration and in vitro invasion. The mass spectrum indicates that the interaction of MUC16 terminal C fragment with the C-STATHmin1 terminal domain inhibits STATHMIN1 phosphorylation to promote combinations with tubulins.
STATHMIN1 Knockdown Inhibits migration and invasion of bile cancer cells in vitro and metastasis in vivo lungs caused by polypeptides Terminal C-terminal MUC16. The level of high expression of MUC16C is consistent with STATHMIN1 is also confirmed in the gallbladder cancer tissue. Our study revealed the mechanism that underlies the gallbladder cancer metastasis related to the level of CA-125, which is useful for CA-125 in the diagnosis and therapy of gallbladder cancer.
Localization of vasoactive polypeptide receptor 1 (VPAC1) in neuroendocrine hypothalamic neuroendocrine neurons; Potential role in circadian prolactin secretion
Prolactin (PRL) is a versatile hormone and presents various physiological functions other than lactation. The release of the PRL from lactotrof in the hypophysis owned in mice is proven to be released with a circadian pattern depending on the physiological state of the animal. The release of the Circadian PRL seems to be a complex involving tonic inhibition by dopamine (DA) neurons in lactotrof and one or even several release factors. Because of the pattern of release of circadian PRL, neurons in the suprachiasmatic nucleus (SCN), “brain clock,” and especially neurons that express neuropeptide vasoactive polypeptide intestine (VIP), have been advised to be involved in the circadian regulation.

In this study, we use immunohistochemical fluorescence, in hybridization histochemistry situ, confocal microscope, three-dimensional reconstruction, and very specific antibodies to visualize the occurrence of VIP 1 and 2 receptors (VPAC1 and VPAC2) in the stained mouse hypothalamic section in combination with VIP , Oxytocin (OXT), Arginine Vasopresin (AVP), and DA (Tyrosine hydroxylase, th). We show that VIP fiber is likely to come from the ventral part of the SCN project to OXT neurons in the magnocelluler part of nucleus paraventricular (PVN).
In PVN, VIP fibers found in the application close to Oxt Neurons exclusively express VPAC1 receptors. Next, we show that Oxt neurons or AVP neurons do not express VPAC2 receptors. The expression of VPAC receptors is also found in blood vessels but not in neurons that express AVP or th. These findings indicate that VIP signaling from the SCN does not directly target neurons involved in the PLL secretion. Furthermore, the findings support the idea that the VIP from neurons in the SCN can regulate the release of circadian oxt in pituitary neurons or posterior modulation as the release factor involved in the temperature regulation of lactotrof.
Pancreas polypeptides but not other members of the Neuropeptide Y family show a moderate relationship with anxiety felt in a fat man
Neuropeptide Y (NPY), Peptide Tyrosine Tyrosine (PYY), and Pancreatic Polypeptide (PP) is an important mediator in two-way communication along the intestinal axis. Most famous for their role in taste rules and their food intake is considered to play an important role in the development of obesity. In addition, evidence of installation shows regulatory functions in anxiety, mood and stress resistance with gender potential differences. In this study, we examined the association of NPY, PYY, and PP plasma levels with anxiety, depression and stress felt in obesity patients.
We analyzed 144 inpatients (90 women, 54 men, BMI: 49.4 kg / m2) in naturalistic care settings for obesity and somatic and mental comorbidity. Fasting blood samples were taken, and the patient completed the psychometric self-assessment questionnaire (GAD-7, PHQ-9, PSQ-20) in the first week after entering and before exiting. The plasma concentration of peptides was measured by Elisa. Women showed higher anxiety (GAD-7: 8.13 ± 5.67 vs 5.93 ± 5.42, p = 0.04) and stress scores (PSQ-20: 52.62 ± 23.5 vs 41.23 ± 0.01 ) than men. In the longitudinal analysis of women with increasing clinically relevant anxiety (≥ 5 points at GAD-7, P <0.001) also showed a significant increase in depression (PHQ-9: 38%, p = 0.002) and PSQ-20 score (23) %, p = 0.005) while male patients who enhanced anxiety only increased in the tension of the PSQ-20 subscale (34%, p = 0.02).
In the man we observed the positive correlation of PP with anxiety scores (GAD-7: R = 0.41, p = 0.007) and with age (r = 0.49, p = 0.001) when entered while NPY correlated negatively with age (r = -0.38), p = 0.01). Instead, there was no significant association (P> 0.05) on the subject of women in cross-sectional and in longitudinal analysis. In conclusion, women who suffer from terrible obesity show greater psychological comorbidity and considerable interaction between them.
PTCHD2 Antibody |
4915-01mg |
ProSci |
0.1 mg |
EUR 436.42 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
4925-002mg |
ProSci |
0.02 mg |
EUR 171.82 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
4925-01mg |
ProSci |
0.1 mg |
EUR 436.42 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
6637-002mg |
ProSci |
0.02 mg |
EUR 171.82 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
PTCHD2 Antibody |
6637-01mg |
ProSci |
0.1 mg |
EUR 436.42 |
|
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism. |
Polyclonal PTCHD2 Antibody |
AMR09590G |
Leading Biology |
0.1 mg |
EUR 659 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PTCHD2 Antibody |
AMR09591G |
Leading Biology |
0.1 mg |
EUR 659 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PTCHD2 Antibody |
AMR09592G |
Leading Biology |
0.1 mg |
EUR 659 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications: |
Human PTCHD2 shRNA Plasmid |
20-abx961520 |
Abbexa |
|
|
|
Polyclonal PTCHD2 Antibody (N-Terminus) |
AMR09593G |
Leading Biology |
0.05mg |
EUR 484 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 (N-Terminus). This antibody is tested and proven to work in the following applications: |
Ptchd2 ORF Vector (Mouse) (pORF) |
ORF055152 |
ABM |
1.0 ug DNA |
EUR 1572 |
PTCHD2 ORF Vector (Human) (pORF) |
ORF028512 |
ABM |
1.0 ug DNA |
Ask for price |
Ptchd2 sgRNA CRISPR Lentivector set (Mouse) |
K3185201 |
ABM |
3 x 1.0 ug |
EUR 339 |
PTCHD2 sgRNA CRISPR Lentivector set (Human) |
K1748901 |
ABM |
3 x 1.0 ug |
EUR 339 |
Canine C-Peptide ELISA Kit |
DLR-C-Peptide-c-48T |
DL Develop |
48T |
EUR 527 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Canine C-Peptide ELISA Kit |
DLR-C-Peptide-c-96T |
DL Develop |
96T |
EUR 688 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Canine C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human C-Peptide ELISA Kit |
DLR-C-Peptide-Hu-48T |
DL Develop |
48T |
EUR 398 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human C-Peptide ELISA Kit |
DLR-C-Peptide-Hu-96T |
DL Develop |
96T |
EUR 511 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Human C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse C-Peptide ELISA Kit |
DLR-C-Peptide-Mu-48T |
DL Develop |
48T |
EUR 450 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse C-Peptide ELISA Kit |
DLR-C-Peptide-Mu-96T |
DL Develop |
96T |
EUR 582 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Mouse C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat C-Peptide ELISA Kit |
DLR-C-Peptide-Ra-48T |
DL Develop |
48T |
EUR 467 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rat C-Peptide ELISA Kit |
DLR-C-Peptide-Ra-96T |
DL Develop |
96T |
EUR 605 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat C-Peptide in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Canine C-Peptide ELISA Kit |
RD-C-Peptide-c-48Tests |
Reddot Biotech |
48 Tests |
EUR 533 |
Canine C-Peptide ELISA Kit |
RD-C-Peptide-c-96Tests |
Reddot Biotech |
96 Tests |
EUR 740 |
Human C-Peptide ELISA Kit |
RD-C-Peptide-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 387 |
Human C-Peptide ELISA Kit |
RD-C-Peptide-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 532 |
Mouse C-Peptide ELISA Kit |
RD-C-Peptide-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 446 |
Mouse C-Peptide ELISA Kit |
RD-C-Peptide-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 615 |
Rat C-Peptide ELISA Kit |
RD-C-Peptide-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 465 |
Rat C-Peptide ELISA Kit |
RD-C-Peptide-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 643 |
Canine C-Peptide ELISA Kit |
RDR-C-Peptide-c-48Tests |
Reddot Biotech |
48 Tests |
EUR 557 |
Canine C-Peptide ELISA Kit |
RDR-C-Peptide-c-96Tests |
Reddot Biotech |
96 Tests |
EUR 774 |
Human C-Peptide ELISA Kit |
RDR-C-Peptide-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 404 |
Human C-Peptide ELISA Kit |
RDR-C-Peptide-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 556 |
Mouse C-Peptide ELISA Kit |
RDR-C-Peptide-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 465 |
Mouse C-Peptide ELISA Kit |
RDR-C-Peptide-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 643 |
Rat C-Peptide ELISA Kit |
RDR-C-Peptide-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 486 |
Rat C-Peptide ELISA Kit |
RDR-C-Peptide-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 672 |
Ptchd2 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K3185202 |
ABM |
1.0 ug DNA |
EUR 154 |
Ptchd2 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3185203 |
ABM |
1.0 ug DNA |
EUR 154 |
Ptchd2 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K3185204 |
ABM |
1.0 ug DNA |
EUR 154 |
PTCHD2 sgRNA CRISPR Lentivector (Human) (Target 1) |
K1748902 |
ABM |
1.0 ug DNA |
EUR 154 |
PTCHD2 sgRNA CRISPR Lentivector (Human) (Target 2) |
K1748903 |
ABM |
1.0 ug DNA |
EUR 154 |
PTCHD2 sgRNA CRISPR Lentivector (Human) (Target 3) |
K1748904 |
ABM |
1.0 ug DNA |
EUR 154 |
Ptchd2 3'UTR GFP Stable Cell Line |
TU167223 |
ABM |
1.0 ml |
Ask for price |
Ptchd2 3'UTR Luciferase Stable Cell Line |
TU117223 |
ABM |
1.0 ml |
Ask for price |
PTCHD2 3'UTR Luciferase Stable Cell Line |
TU019132 |
ABM |
1.0 ml |
EUR 1394 |
PTCHD2 3'UTR GFP Stable Cell Line |
TU069132 |
ABM |
1.0 ml |
EUR 1394 |
PTCHD2 Protein Vector (Mouse) (pPB-C-His) |
PV220606 |
ABM |
500 ng |
EUR 2305 |
PTCHD2 Protein Vector (Mouse) (pPB-N-His) |
PV220607 |
ABM |
500 ng |
EUR 2305 |
PTCHD2 Protein Vector (Mouse) (pPM-C-HA) |
PV220608 |
ABM |
500 ng |
EUR 2305 |
PTCHD2 Protein Vector (Mouse) (pPM-C-His) |
PV220609 |
ABM |
500 ng |
EUR 2305 |
PTCHD2 Protein Vector (Human) (pPB-C-His) |
PV114046 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Human) (pPB-N-His) |
PV114047 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Human) (pPM-C-HA) |
PV114048 |
ABM |
500 ng |
Ask for price |
PTCHD2 Protein Vector (Human) (pPM-C-His) |
PV114049 |
ABM |
500 ng |
Ask for price |
Mouse Patched domain- containing protein 2, Ptchd2 ELISA KIT |
ELI-43078m |
Lifescience Market |
96 Tests |
EUR 865 |
Human Patched domain- containing protein 2, PTCHD2 ELISA KIT |
ELI-44851h |
Lifescience Market |
96 Tests |
EUR 824 |
Ptchd2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
K3185205 |
ABM |
3 x 1.0 ug |
EUR 376 |
PTCHD2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
K1748905 |
ABM |
3 x 1.0 ug |
EUR 376 |
Ptchd2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
K3185206 |
ABM |
1.0 ug DNA |
EUR 167 |
Ptchd2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3185207 |
ABM |
1.0 ug DNA |
EUR 167 |
Ptchd2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K3185208 |
ABM |
1.0 ug DNA |
EUR 167 |
PTCHD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
K1748906 |
ABM |
1.0 ug DNA |
EUR 167 |
PTCHD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
K1748907 |
ABM |
1.0 ug DNA |
EUR 167 |
PTCHD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K1748908 |
ABM |
1.0 ug DNA |
EUR 167 |
TKD Peptide (Hsp70 Peptide) (Hsp70 Peptide) |
SIH-118A |
Stressmarq |
1 mg |
EUR 312 |
|
Description: The substance TKD Peptide (Hsp70 Peptide) is a hsp70 peptide. It is synthetically produced and has a purity of >98%. The pure substance is solid which is In aqueous solution. |
Human Connecting Peptide (C-Peptide) Peptide |
abx670072-05mg |
Abbexa |
0.5 mg |
EUR 565 |
|
TKD Peptide (Hsp70 Peptide): FITC (Hsp70 Peptide) |
SIH-119A |
Stressmarq |
1 mg |
EUR 359 |
|
Description: The substance TKD Peptide (Hsp70 Peptide): FITC is a hsp70 peptide. It is synthetically produced and has a purity of >98%. The pure substance is solid which is In aqueous solution. |
Rat Connecting Peptide (C-Peptide) Peptide (OVA) |
20-abx651058 |
Abbexa |
-
EUR 425.00
-
EUR 230.00
-
EUR 1149.00
-
EUR 495.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
TKD Peptide (Hsp70 Peptide) |
abx076809-1mg |
Abbexa |
1 mg |
EUR 495 |
|
C-Peptide Blocking Peptide |
3277BP-50 |
Biovision |
|
EUR 153 |
TKD Peptide (Hsp70 Peptide) (FITC) |
abx076810-1mg |
Abbexa |
1 mg |
EUR 565 |
|
Connecting Peptide (C-Peptide) Antibody |
20-abx100155 |
Abbexa |
-
EUR 258.00
-
EUR 133.00
-
EUR 606.00
-
EUR 328.00
-
EUR 230.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Peptide YY (PYY) Peptide |
20-abx068451 |
Abbexa |
-
EUR 578.00
-
EUR 258.00
-
EUR 1678.00
-
EUR 676.00
-
EUR 425.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Peptide YY (PYY) Peptide |
20-abx068452 |
Abbexa |
-
EUR 592.00
-
EUR 258.00
-
EUR 1776.00
-
EUR 704.00
-
EUR 439.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Peptide YY (PYY) Peptide |
20-abx068453 |
Abbexa |
-
EUR 620.00
-
EUR 272.00
-
EUR 1859.00
-
EUR 732.00
-
EUR 453.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Connecting Peptide (C-Peptide) Antibody |
abx021134-100ug |
Abbexa |
100 ug |
EUR 481 |
|
Connecting Peptide (C-Peptide) Antibody |
abx021135-1mg |
Abbexa |
1 mg |
EUR 739 |
|
Connecting Peptide (C-Peptide) Antibody |
abx022864-01ml |
Abbexa |
0.1 ml |
EUR 578 |
|
Connecting Peptide (C-peptide) Antibody |
abx023812-1mg |
Abbexa |
1 mg |
EUR 739 |
|
Connecting Peptide (C-Peptide) Antibody |
abx411178-025mg |
Abbexa |
0.25 mg |
EUR 565 |
|
Connecting Peptide (C-Peptide) Antibody |
abx414631-02mg |
Abbexa |
0.2 mg |
EUR 565 |
|
Connecting Peptide (C-Peptide) Antibody |
abx414632-02mg |
Abbexa |
0.2 mg |
EUR 565 |
|
Connecting Peptide (C-Peptide) Antibody |
abx414633-02mg |
Abbexa |
0.2 mg |
EUR 565 |
|
Connecting Peptide (C-Peptide) Antibody |
abx414789-02mg |
Abbexa |
0.2 mg |
EUR 565 |
|
Connecting Peptide (C-Peptide) Antibody |
abx414790-02mg |
Abbexa |
0.2 mg |
EUR 565 |
|
Human Vasoactive Intestinal Peptide (VIP) Peptide |
20-abx069654 |
Abbexa |
-
EUR 662.00
-
EUR 272.00
-
EUR 2040.00
-
EUR 787.00
-
EUR 481.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Vasoactive Intestinal Peptide (VIP) Peptide |
20-abx069655 |
Abbexa |
-
EUR 690.00
-
EUR 286.00
-
EUR 2124.00
-
EUR 815.00
-
EUR 495.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Vasoactive Intestinal Peptide (VIP) Peptide |
20-abx069656 |
Abbexa |
-
EUR 704.00
-
EUR 286.00
-
EUR 2165.00
-
EUR 829.00
-
EUR 495.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Atrial Natriuretic Peptide (ANP) Peptide |
20-abx065482 |
Abbexa |
-
EUR 676.00
-
EUR 286.00
-
EUR 2082.00
-
EUR 801.00
-
EUR 481.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Atrial Natriuretic Peptide (ANP) Peptide |
20-abx065483 |
Abbexa |
-
EUR 578.00
-
EUR 258.00
-
EUR 1720.00
-
EUR 690.00
-
EUR 425.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Even though we only observed the PP association with anxiety and age with NPY and PP in men, suggesting the possibility of the effect of sex hormones on the NPY system. However, an increase in anxiety scores does not lead to significant changes in NPY.